Relx (RELX) Accumulated Expenses (2017 - 2025)

On a quarterly basis, Accumulated Expenses rose 19.1% to $1.3 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $1.3 billion, a 19.1% increase, with the full-year FY2025 number at $1.3 billion, up 19.1% from a year prior.

Relx (RELX) has 9 years of Accumulated Expenses data on record, last reported at $1.3 billion in Q4 2025.

  • Accumulated Expenses reached $1.3 billion in Q4 2025 per RELX's latest filing, up from $1.1 billion in the prior quarter.
  • Over the last five years, Accumulated Expenses for RELX hit a ceiling of $1.3 billion in Q4 2025 and a floor of $967.9 million in Q4 2021.
  • A 5-year average of $1.1 billion and a median of $1.0 billion in 2023 define the central range for Accumulated Expenses.
  • Peak YoY movement for Accumulated Expenses: grew 2.28% in 2022, then rose 19.1% in 2025.
  • Tracing RELX's Accumulated Expenses over 5 years: stood at $967.9 million in 2021, then rose by 2.28% to $990.0 million in 2022, then grew by 5.57% to $1.0 billion in 2023, then rose by 4.52% to $1.1 billion in 2024, then grew by 19.1% to $1.3 billion in 2025.
  • Business Quant data shows Accumulated Expenses for RELX at $1.3 billion in Q4 2025, $1.1 billion in Q4 2024, and $1.0 billion in Q4 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Relx 81.40 Bn 81.16 Bn -
2 Rentokil Initial 79.56 Bn 78.10 Bn -
3 Cintas 69.26 Bn 69.08 Bn 1.45 Bn
4 Copart 33.09 Bn 28.01 Bn 971.24 Mn
5 UL Solutions 20.56 Bn 20.32 Bn 381.00 Mn
6 Global Payments 19.88 Bn 14.69 Bn 1.70 Bn
7 Rb Global 19.08 Bn 18.89 Bn 869.50 Mn
8 Aramark 13.57 Bn 13.16 Bn 426.35 Mn
9 Amentum Holdings 5.65 Bn 5.74 Bn 345.00 Mn
10 Dolby Laboratories 5.15 Bn 4.56 Bn 350.90 Mn

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 1.30 Bn
Dec 31, 2024 1.09 Bn
Dec 31, 2023 1.05 Bn
Dec 31, 2022 989.95 Mn
Dec 31, 2021 967.87 Mn
Dec 31, 2020 837.17 Mn
Dec 31, 2019 879.44 Mn
Dec 31, 2018 914.89 Mn
Dec 31, 2017 880.24 Mn